We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




High Malaria Parasitemia Affects Rapid Diagnostic Tests

By LabMedica International staff writers
Posted on 26 Jul 2010
Rapid diagnostic tests (RDTs) for malaria are devices that detects malaria antigen in a small amount of blood. More...
Monoclonal antibodies directed against the target parasite antigen are impregnated on a test strip.

A small amount of finger prick blood is put on the immunochromatographic strip and the result, usually a colored test line, is obtained in 5-20 minutes. RDTs require no capital investment or electricity, are simple to perform, and are easy to interpret.

Most malaria RDTs detect Plasmodium falciparum, and an antigen common to all four species. Plasmodium vivax-specific RDTs target P. vivax-specific parasite lactate dehydrogenase (Pv-pLDH). P. falciparum parasites cause the fatal form of malaria and patients may need hospitalization, while P. vivax and the other species are more benign.

RDTs are widely used in both the developed and developing world and they are replacing the traditional methods that require highly trained and skilled microscopists. In a recent study, nine P. vivax specific RDTs were tested with blood from 85 patients with P. falciparum whose parasite density was equal or greater than 2%. The RDTs included two-band (detecting Pv-pLDH), three-band (detecting P. falciparum-antigen and Pv-pLDH) and four-band RDTs (detecting P. falciparum, Pv-pLDH and pan-pLDH). False positive Pv-pLDH lines were observed in six of the nine RDTs, including two- three- and four-band RDTs. They occurred in the individual RDT brands at frequencies ranging from 8.2% to 29.1%. Over 22% of samples generated a false positive Pv-pLDH line at least two RDT brands. False positive lines were of medium or strong line intensity in 18% of the samples.

False positive Pv-pLDH lines in P. falciparum samples with high parasite density occurred in six of the nine P. vivax-specific RDTs. This is of concern, as both malarial parasites are cocirculating in many regions. The diagnosis of life-threatening P. falciparum malaria may be missed (two-band Pv-pLDH RDT), or the patient may be treated incorrectly with primaquine (three- or four-band RDTs) which may cause hemolysis in patients with glucose-6 phosphate dehydrogenase (G6PD) deficiency.

As batch lots of RDTs are variable in their specificity, the authors of the study did not give manufactures details, which were chosen from the World Health Organization's (WHO; Geneva, Switzerland) list of recommended kits. The results of the study were published in the July 2010 issue of the Malaria Journal.

Related Links:
WHO




New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The VeraBIND Tau assay is a novel blood test that identifies the presence of active tau pathology (Photo courtesy of 123RF)

First Blood-Based Test Measures Key Alzheimer's Biomarker in Asymptomatic and Symptomatic Individuals

Alzheimer’s disease (AD), the sixth leading cause of death in the United States, affects an estimated 7.2 million Americans aged 65 or older. Current diagnostic methods for AD are often invasive, expensive,... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.